Martens Rachel Yap has filed 5 insider transactions across 1 company since February 2026.
Most recent transaction: a option exercise of 67090 shares of LEXICON PHARMACEUTICALS, INC. ($LXRX) on February 28, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Martens Rachel Yap | SVP, Partnerships & Corp Strat | M | Common Stock | 67090 | $0.00 | 67,090.0000 | 365,780,799 | 9999.99% | 0.02% |
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Martens Rachel Yap | SVP, Partnerships & Corp Strat | F | Common Stock | 35826 | $1.47 | 31,264.0000 | 365,780,799 | 53.40% | 0.01% |
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Martens Rachel Yap | SVP, Partnerships & Corp Strat | M | Restricted Stock Units | 67090 | $0.00 | 134,180.0000 | 365,780,799 | 33.33% | 0.02% |
| Feb. 12, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Martens Rachel Yap | SVP, Partnerships & Corp Strat | A | Restricted Stock Units | 193740 | $0.00 | 193,740.0000 | 365,780,799 | 9999.99% | 0.05% |
| Feb. 12, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Martens Rachel Yap | SVP, Partnerships & Corp Strat | A | Stock Option (Right to Buy) | 290620 | $0.00 | 290,620.0000 | 365,780,799 | 9999.99% | 0.08% |